GLP-1Ra Impact on Metabolic Outcomes in Stage 2 T1DM While Receiving Teplizumab

Clinical trial NCT06338553 · RECRUITING

Trial details

NCT number: NCT06338553
Sponsor: Vanderbilt University Medical Center
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Type 1 Diabetes

Start date: 2024-06-12
Primary completion: 2027-03-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.